Medtronic EBITDA Margin 2010-2025 | MDT

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Medtronic (MDT) over the last 10 years. The current EBITDA margin for Medtronic as of July 31, 2025 is .
Medtronic EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-07-31 $34.20B $9.07B 26.51%
2025-04-30 $33.54B $8.82B 26.29%
2025-01-31 $33.20B $8.25B 24.84%
2024-10-31 $33.00B $8.05B 24.40%
2024-07-31 $32.58B $7.79B 23.92%
2024-04-30 $32.36B $7.79B 24.08%
2024-01-31 $32.32B $8.33B 25.78%
2023-10-31 $31.96B $8.27B 25.88%
2023-07-31 $31.56B $8.33B 26.40%
2023-04-30 $31.23B $8.18B 26.20%
2023-01-31 $30.77B $8.30B 26.96%
2022-10-31 $30.81B $8.56B 27.78%
2022-07-31 $31.07B $8.72B 28.07%
2022-04-30 $31.69B $8.46B 26.70%
2022-01-31 $31.79B $8.39B 26.39%
2021-10-31 $31.80B $8.01B 25.20%
2021-07-31 $31.60B $7.37B 23.34%
2021-04-30 $30.12B $7.19B 23.86%
2021-01-31 $27.93B $5.89B 21.08%
2020-10-31 $27.87B $6.23B 22.37%
2020-07-31 $27.93B $6.65B 23.83%
2020-04-30 $28.91B $7.45B 25.78%
2020-01-31 $31.06B $9.08B 29.23%
2019-10-31 $30.89B $8.99B 29.12%
2019-07-31 $30.67B $9.17B 29.89%
2019-04-30 $30.56B $8.93B 29.21%
2019-01-31 $30.56B $8.91B 29.15%
2018-10-31 $30.38B $8.79B 28.94%
2018-07-31 $29.95B $9.17B 30.61%
2018-04-30 $29.95B $9.28B 31.00%
2018-01-31 $29.73B $9.07B 30.52%
2017-10-31 $29.64B $8.86B 29.88%
2017-07-31 $29.93B $8.41B 28.09%
2017-04-30 $29.71B $8.30B 27.94%
2017-01-31 $29.36B $8.21B 27.96%
2016-10-31 $29.01B $8.40B 28.96%
2016-07-31 $28.73B $8.28B 28.83%
2016-04-30 $28.83B $8.21B 28.47%
2016-01-31 $28.57B $6.76B 23.67%
2015-10-31 $25.95B $6.24B 24.03%
2015-07-31 $23.26B $5.63B 24.22%
2015-04-30 $20.26B $5.15B 25.41%
2015-01-31 $17.52B $4.83B 27.55%
2014-10-31 $17.37B $4.52B 26.01%
2014-07-31 $17.20B $4.54B 26.39%
2014-04-30 $17.01B $4.67B 27.47%
2014-01-31 $16.90B $5.58B 33.04%
2013-10-31 $16.76B $5.80B 34.59%
2013-07-31 $16.67B $5.79B 34.71%
2013-04-30 $16.59B $5.68B 34.23%
2013-01-31 $16.43B $5.68B 34.58%
2012-10-31 $16.32B $5.61B 34.37%
2012-07-31 $16.25B $5.66B 34.81%
2012-04-30 $16.18B $5.67B 35.01%
2012-01-31 $15.86B $5.47B 34.45%
2011-10-31 $15.80B $5.46B 34.57%
2011-07-31 $15.68B $5.35B 34.14%
2011-04-30 $15.51B $5.27B 34.00%
2011-01-31 $15.30B $5.34B 34.90%
2010-10-31 $15.30B $5.46B 35.71%
2010-07-31 $15.23B $5.56B 36.53%
2010-04-30 $15.39B $5.65B 36.73%
2010-01-31 $15.45B $5.23B 33.82%
2009-10-31 $15.09B $4.91B 32.54%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $119.046B $33.537B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.889B 27.07
Boston Scientific (BSX) United States $156.325B 37.28
Stryker (SYK) United States $149.639B 30.46
EssilorLuxottica (ESLOY) France $141.259B 0.00
Lonza Group Ag (LZAGY) Switzerland $49.750B 0.00
Haleon (HLN) United Kingdom $43.950B 25.13
ResMed (RMD) United States $40.192B 28.74
Agilent Technologies (A) United States $35.696B 23.06
GE HealthCare Technologies (GEHC) United States $33.662B 15.82
Terumo (TRUMY) Japan $26.606B 31.53
Koninklijke Philips (PHG) Netherlands $26.557B 17.57
Insulet (PODD) United States $23.925B 80.16
Zimmer Biomet Holdings (ZBH) United States $21.018B 13.38
Smith & Nephew SNATS (SNN) United Kingdom $16.402B 0.00
Baxter (BAX) United States $12.681B 9.80
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $8.061B 29.61
Lantheus Holdings (LNTH) United States $3.733B 10.09
Envista Holdings (NVST) United States $3.520B 24.63
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Prestige Consumer Healthcare (PBH) United States $3.349B 14.86
Perrigo (PRGO) Ireland $3.266B 8.16
ICU Medical (ICUI) United States $3.151B 21.46
Haemonetics (HAE) United States $2.628B 11.73
Acuren (TIC) United States $2.261B 0.00
Curaleaf Holdings (CURLF) Canada $2.213B 0.00
LeMaitre Vascular (LMAT) United States $2.159B 46.29
QuidelOrtho (QDEL) United States $1.948B 12.26
Green Thumb Industries (GTBIF) United States $1.840B 79.00
AtriCure (ATRC) United States $1.838B 0.00
Tilray Brands (TLRY) Canada $1.519B 0.00
Phibro Animal Health (PAHC) United States $1.503B 17.74
AdaptHealth (AHCO) United States $1.284B 18.25
Neogen (NEOG) United States $1.249B 19.83
BioLife Solutions (BLFS) United States $1.200B 2505.00
InMode (INMD) Israel $0.944B 8.74
Kestra Medical Technologies (KMTS) United States $0.829B 0.00
Valneva SE (VALN) France $0.753B 0.00
Cresco Labs (CRLBF) United States $0.740B 0.00
SNDL (SNDL) Canada $0.704B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.618B 0.00
Verano Holdings (VRNOF) United States $0.615B 0.00
ZimVie (ZIMV) United States $0.532B 20.52
Evolus (EOLS) United States $0.494B 0.00
Surmodics (SRDX) United States $0.487B 0.00
VAREX IMAGING (VREX) United States $0.479B 16.50
CeriBell (CBLL) United States $0.434B 0.00
Canopy Growth (CGC) Canada $0.432B 0.00
Owens & Minor (OMI) United States $0.379B 3.36
Sanuwave Health (SNWV) United States $0.357B 0.00
TerrAscend (TSNDF) Canada $0.352B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Aurora Cannabis (ACB) Canada $0.306B 0.00
Sanara MedTech (SMTI) United States $0.300B 0.00
Brainsway (BWAY) Israel $0.294B 59.85
High Tide (HITI) Canada $0.292B 0.00
Capricor Therapeutics (CAPR) United States $0.287B 0.00
Viemed Healthcare (VMD) United States $0.286B 21.68
Omeros (OMER) United States $0.283B 0.00
TriSalus Life Sciences (TLSI) United States $0.260B 0.00
Cerus (CERS) United States $0.251B 0.00
OraSure Technologies (OSUR) United States $0.242B 0.00
Organigram Global (OGI) Canada $0.232B 0.00
Vireo Growth (VREOF) United States $0.219B 0.00
Exagen (XGN) United States $0.217B 0.00
Quanterix (QTRX) United States $0.211B 0.00
Utah Medical Products (UTMD) United States $0.199B 16.63
FitLife Brands (FTLF) United States $0.175B 21.53
Biote (BTMD) United States $0.170B 5.64
Jushi Holdings (JUSHF) United States $0.149B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.111B 0.00
Fonar (FONR) United States $0.099B 12.78
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Apyx Medical (APYX) United States $0.075B 0.00
Agape ATP (ATPC) $0.066B 0.00
Safety Shot (SHOT) United States $0.062B 0.00
MariMed (MRMD) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.058B 33.68
Zynex (ZYXI) United States $0.050B 0.00
Veru (VERU) United States $0.048B 0.00
Modular Medical (MODD) United States $0.040B 0.00
Nephros (NEPH) United States $0.040B 31.08
United-Guardian (UG) United States $0.039B 15.02
Senestech (SNES) United States $0.024B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
INLIF (INLF) $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Sharps Technology (STSS) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00